Diet swap study suggests it may never be too late to modify colon cancer risk

the ONA take:

According to a new study published in the journal Nature Communications, African-Americans and Africans who swapped their usual diets for 2 weeks also exchanged their respective colon cancer risks as a result of alterations to their gut flora.

For the study, 20 African-American and 20 rural South African volunteers ate meals typical of the other group for 2 weeks.

Analyses of fecal and colon content samples showed that each group took on the other's rates of turnover of intestinal lining cells, levels of fiber fermentation, and biomarkers of inflammation and bacterial metabolic activity that are linked with colon cancer risk.

The African-American diet, which consists of more animal protein and fat, and less soluble fiber than the typical African diet is thought to increase the risk for colon cancer.

"These findings are really very good news," said principal investigator Stephen O'Keefe, M.D. professor of medicine, Division of Gastroenterology, Hepatology and Nutrition at the Pitt School of Medicine. "In just two weeks, a change in diet from a Westernized composition to a traditional African high-fiber, low-fat diet reduced these biomarkers of cancer risk indicating that it is likely never too late to modify the risk of colon cancer."

Diet swap study suggests it may never be too late to modify colon cancer risk
African-Americans who swapped their usual diets for 2 weeks also exchanged their respective colon cancer risks.
African-Americans and Africans who swapped their typical diets for just two weeks similarly exchanged their respective risks of colon cancer as reflected by alterations of their gut bacteria.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs